Skip to main content
Clinical Trials/CTRI/2017/06/008903
CTRI/2017/06/008903
Active, not recruiting
未知

A randomized, double blind, controlled clinical trial to assess the Efficacy and safety of liposomal Curcumin compared with Curcumin (non-liposomal) on inflammation in subjects with metabolic syndrome

CureSupport0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Metabolic syndrome
Sponsor
CureSupport
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
CureSupport

Eligibility Criteria

Inclusion Criteria

  • 1\. 18 years of age and above
  • 2\. Metabolic abnormalities with or without alcohol consumption and/or smoking
  • 3\. Diagnosis of MetS ie. the presence of three or more criteria of the modified National Cholesterol Education Programs Adult Treatment Panel III ( NCEP ATP III):
  • 3\.1 Waist circumference 90 cm in men and 80 cm in women
  • 3\.2 Hypertriglyceridemia \>\= 150 mg/dl
  • 3\.3 High density lipoprotein (HDL) cholesterol 40 mg/dl in males and 50 mg/dl in females
  • 3\.4 Blood pressure \>\= 130/85 mm Hg
  • 3\.5 Fasting plasma glucose \>\= 110 mg/dl
  • 4\.0 Patients willing to provide written informed consent

Exclusion Criteria

  • 1\. Pregnancy or breastfeeding,
  • 2\. lack of compliance with the study medication (defined as not using the medication for \>1 week),
  • 3\. Participation in a concomitant trial,
  • 4\. Hypersensitivity to the study medication,
  • 5\. Presence of malignancies
  • 6\. Impossibility to give informed consent.
  • 7\. Intake of drugs or dietary supplements
  • 8\. Previous illnesses such as heart attack, cancer or dementia
  • 9\. Addiction illness

Outcomes

Primary Outcomes

Not specified

Similar Trials